Agilent Technologies, Inc. $A Shares Purchased by Vaughan Nelson Investment Management L.P.

Vaughan Nelson Investment Management L.P. boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 2.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 207,277 shares of the medical research company’s stock after buying an additional 4,535 shares during the quarter. Vaughan Nelson Investment Management L.P.’s holdings in Agilent Technologies were worth $23,625,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of A. Bridgefront Capital LLC acquired a new position in Agilent Technologies in the 3rd quarter valued at $1,323,000. Wellington Management Group LLP lifted its holdings in Agilent Technologies by 4.8% in the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after purchasing an additional 433,342 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in Agilent Technologies by 4.3% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after purchasing an additional 24,687 shares during the last quarter. Generation Investment Management LLP boosted its stake in Agilent Technologies by 10.1% during the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after purchasing an additional 582,093 shares during the last quarter. Finally, Champlain Investment Partners LLC grew its holdings in shares of Agilent Technologies by 33.3% during the third quarter. Champlain Investment Partners LLC now owns 895,770 shares of the medical research company’s stock worth $114,972,000 after buying an additional 223,750 shares in the last quarter.

Analyst Upgrades and Downgrades

A has been the subject of a number of recent research reports. Piper Sandler began coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price for the company. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. UBS Group cut their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Morgan Stanley decreased their target price on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. Finally, Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $160.93.

Agilent Technologies Stock Down 0.6%

NYSE A opened at $126.34 on Tuesday. The business’s fifty day simple moving average is $121.70 and its 200-day simple moving average is $126.60. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The firm has a market cap of $35.68 billion, a PE ratio of 25.37, a P/E/G ratio of 2.26 and a beta of 1.26. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the prior year, the firm posted $1.31 earnings per share. Agilent Technologies’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 6 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.